Darcy Forman - Oct 6, 2021 Form 4 Insider Report for Science 37 Holdings, Inc. (SNCE)

Role
Chief Delivery Officer
Signature
/s/ Christine Pellizzari, Attorney-in-Fact for Darcy Forman
Stock symbol
SNCE
Transactions as of
Oct 6, 2021
Transactions value $
$0
Form type
4
Date filed
10/8/2021, 09:58 PM
Next filing
Jan 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNCE Common Stock Award +42.4K 42.4K Oct 6, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNCE Stock Option Award +93.6K 93.6K Oct 6, 2021 Common Stock 93.6K $0.40 Direct F1, F2
transaction SNCE Stock Option Award +136K 136K Oct 6, 2021 Common Stock 136K $0.28 Direct F1, F3
transaction SNCE Stock Option Award +136K 136K Oct 6, 2021 Common Stock 136K $0.82 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the business combination of LifeSci Acquisition II Corp and Science 37, Inc. ("Old Science 37"), as contemplated by that certain agreement and plan of merger, dated May 6, 2021 (the "Merger Agreement"), (a) each share of common stock of Old Science 37 outstanding immediately prior to the effective time of the business combination was converted into approximately 1.8153 shares of the Issuer's Common Stock, (b) (the "Conversion Ratio"); and (b) each outstanding stock option of Old Science 37 was converted into a corresponding option to purchase shares of the Issuer's Common Stock as adjusted for the Conversion Ratio
F2 Stock Option is currently vested and exercisable as to 17,019 of the underlying shares, and the remaining shares will vest in equal monthly installments until fully vested on January 6, 2024, subject to the executive's continued service through the applicable vesting date.
F3 Stock Option is currently vested and exercisable as to 45,382 of the underlying shares, and the remaining shares will vest in equal monthly installments until fully vested on June 5, 2024, subject to the executive's continued service through the applicable vesting date.
F4 Represents an option vesting with respect to 25% of the shares subject to the option on the first anniversary of the vesting start date, 1/21/2021, and with respect to 1/48th of the shares subject to the option on each monthly anniversary of the applicable vesting start date thereafter, subject to the executive's continued service through the applicable vesting date.